氢化可的松治疗肺炎支原体引起的小儿大叶性肺炎51例疗效观察

Efficacy of hydrocortisone in the treatment of 51 children with large lobar pneumonia caused by Mycoplasma pneumoniae

目的探究对于肺炎支原体引起的大叶性肺炎小儿患者使用氢化可的松进行治疗的临床效果。方法将本院2014年11月至2017年11月期间接收的102例由肺炎支原体引起的大叶性肺炎患儿随机分成实验组和对照组,每组51例;对照组运用常规的临床治疗方式;实验组使用氢化可的松进行治疗;比较两组患者在咳嗽消退、退热、痰液消失以及啰音消失的用时差异,并分析比较两组药物方案的临床疗效。结果实验组患者在咳嗽消退、退热、痰液消失以及啰音消失的用时方面均明显少于对照组,临床治愈率更高,两组间比较差异有统计学意义(P<0.05)。结论采用氢化可的松治疗肺炎支原体引起的大叶性肺炎小儿患者,临床效果显著,可有效促进患者康复。

Objective To investigate the clinical effect of hydrocortisone in treating children with mycoplasma pneumoniae caused by mycoplasma pneumoniae. Methods From November 2014 to November 2017, 102 cases received from bronchitis pneumoniae in our hospital were treated with hydrocortisone. Body-induced lobar pneumonia children were randomly divided into experimental group and control group with 51 cases in each group. The control group was treated with routine clinical treatment, the experimental group was treated with hydrocortisone, and the duration of cough, fever, sputum and rale disappeared was compared between the two groups. The clinical efficacy of the two drug regimens was analyzed and compared. Results The patients in the experimental group were treated with The duration of cough, fever, sputum and rale disappearance were significantly less than those in the control group, and the clinical cure rate was higher than that in the control group. Conclusion Hydrocortisone is effective in the treatment of children with mycoplasma pneumoniae induced by mycoplasma pneumoniae.